Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2021 08:30 ET | Source: Sera Prognostics

Sera Prognostics Appoints Dr. Paul Kearney as Chief Data Officer

Brings extensive data science, bioinformatics and proteomics experience to foster further product innovation and informed healthcare insights into pregnancy SALT LAKE CITY, Sept. 28, 2021 ...
September 20, 2021 08:30 ET | Source: Sera Prognostics

Sera Prognostics to be Added to Russell 2000 Index

SALT LAKE CITY, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
September 15, 2021 08:00 ET | Source: Sera Prognostics

Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer

SALT LAKE CITY, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
September 14, 2021 08:00 ET | Source: Sera Prognostics

Sera Prognostics Announces Publication of Health Economic Analysis Supporting PreTRM® Test-and-Treat Strategy to Improve Maternal and Infant Health

Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births,...
September 13, 2021 08:00 ET | Source: Sera Prognostics

Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit

SALT LAKE CITY, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
August 30, 2021 16:05 ET | Source: Sera Prognostics

Sera Prognostics Reports Second Quarter 2021 Financial Results

SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
August 17, 2021 08:00 ET | Source: Sera Prognostics

Sera Prognostics’ PreTRM® Test and Treat Strategy Benefits Demonstrated by Results of Prospective, Randomized Controlled Intervention Trial Evaluating Clinical Utility

Study demonstrates positive impact of the company’s PreTRM® test and treat strategy on improving neonatal healthcare NICU and total hospital length-of-stay in preemies reduced by more than 70% Faster...
July 14, 2021 21:03 ET | Source: Sera Prognostics

Sera Prognostics Announces Pricing of Initial Public Offering

SALT LAKE CITY, July 14, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy...
May 19, 2021 08:30 ET | Source: Sera Prognostics

Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth

- The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., The Pregnancy Company®...
May 18, 2021 16:13 ET | Source: Sera Prognostics

Evaluation of Health and Economic Benefit of the PreTRM® Test-And-Treat Strategy to Improve Maternal and Infant Health Among Commercially Insured in the US

– Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings SALT LAKE CITY, May 18, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy...